2024 Rome, Italy

IV-098 Eunsol Yang
Translational tool-based phase 2 clinical outcome predictions of the novel diarylquinoline TBAJ-587 for the treatment of tuberculosis, compared to bedaquiline and TBAJ-876
Thursday 15:00-16:30